David Engblom, a distinguished Professor of Neurobiology at Linköping University, Sweden, has been honored with the prestigious 2026 Onkel Adam Prize. This award, the highest accolade conferred by the Faculty of Medicine at Linköping University, recognizes his groundbreaking work on understanding the complex interactions between the brain and the immune system during illness. Engblom’s research sheds light on the neural mechanisms that influence how we experience symptoms and behavioral changes when afflicted by inflammatory conditions.
When individuals fall ill with common respiratory infections such as the cold or flu, subtle yet profound changes occur not only physically but psychologically. Many report feelings of malaise accompanied by depression-like symptoms, social withdrawal, and a pervasive sense of unease. These symptoms, often dismissed as transient side effects of sickness, are increasingly understood to result from the activation of the body’s immune system. Inflammatory signals generated peripherally propagate to the brain, altering neural circuits that govern mood, motivation, and cognition. Engblom’s scientific journey has delved deeply into decoding how peripheral inflammation impacts brain function and how such changes contribute to what is now termed “sickness behavior.”
The phenomenon where immune activation reshapes brain function is not limited to acute infections. Chronic inflammatory disorders such as rheumatoid arthritis and inflammatory bowel disease manifest persistent neurobehavioral symptoms. Engblom’s work investigates the molecular and cellular pathways by which inflammatory mediators communicate with brain cells, shaping behavior and emotional state. His research elucidates how pro-inflammatory cytokines and metabolic changes evoke neurobiological responses that mimic depressive syndromes, thus providing a mechanistic basis for the intersection between immunology and psychiatry.
Engblom emphasizes that understanding these brain-immune interactions transcends academic curiosity. Pinpointing the contributors to illness-induced neurobehavioral alterations opens avenues for targeted therapeutic interventions that could alleviate the psychological suffering accompanying physical disease. Moreover, these insights have broad implications for improving patient care across a spectrum of inflammatory illnesses by integrating neurobiological perspectives into treatment strategies, ultimately enhancing quality of life for affected individuals.
The path that led David Engblom to becoming a trailblazing scientist in neuroimmune research was serendipitous. Initially a medical student, he embarked on research midway through his studies, intending to return to clinical training. However, the allure of discovery and the compelling questions posed by brain-immune crosstalk captivated him profoundly. This unexpected pivot has been met with considerable acclaim, as reflected by numerous prestigious grants and awards recognizing the scientific rigor and impact of his work.
Many in academia will find Engblom’s philosophy about career flexibility inspiring. He advocates for embracing opportunities that arise unexpectedly rather than adhering rigidly to predetermined plans. His own success story exemplifies how openness to diverse experiences and adapting to evolving interests can catalyze significant scientific breakthroughs and career fulfillment. For aspiring researchers, this underscores the importance of intellectual curiosity and resilience in the pursuit of innovation.
In addition to his contributions to research, Engblom has distinguished himself as an exceptional educator. He is extensively involved in teaching medical students, imparting complex neurobiological concepts with clarity and engagement. His pedagogical excellence has earned him the “Kandidat Kork” teaching award multiple times, a testament to his dedication and ability to inspire the next generation of medical professionals. His dual excellence in research and teaching exemplifies the ideal academic role model.
The Onkel Adam Prize, awarded to Engblom, was instituted in 2020 through an endowment from Bengt Normann, a descendant of the eminent 19th-century physician Carl Anton Wetterbergh, who was known by the pseudonym Onkel Adam. The prize aims to foster outstanding medical research at Linköping University while commemorating Wetterbergh’s legacy. With a monetary value of SEK 400,000, this distinction celebrates outstanding scientific accomplishments and encourages continued innovation within the faculty.
Engblom humbly attributes his success to the collective efforts of his research team, underscoring the collaborative nature of modern science. While early in his career he was hands-on with experimental work, he now assumes a role akin to that of a coach guiding a team, helping to steer and mentor his colleagues and students as they execute complex investigations. This leadership fosters an environment in which diverse ideas converge, leading to robust and impactful scientific findings.
His sophisticated investigations employ advanced neurobiological techniques to unravel the intricate dialogue between immune signals and neuronal networks. These methods include molecular assays to profile cytokine expression, in vivo imaging to observe brain activity during inflammatory states, and behavioral paradigms that quantify sickness behaviors in animal models. Such a multidisciplinary approach is crucial in addressing the multifaceted nature of neuroimmune communication pathways.
Engblom’s findings have broader implications extending to the understanding of depression and psychiatric disorders linked to systemic inflammation. By elucidating how inflammatory mediators can precipitate behavioral changes traditionally associated with mental illness, his research bridges the gap between immunology and neuroscience. This integrative perspective could revolutionize how neuropsychiatric symptoms are diagnosed and treated, especially in patients with coexisting inflammatory diseases.
The university’s Faculty of Medicine and Health Sciences, led by Dean Lena Jonasson, praised Engblom’s stellar accomplishments not only in research but also his contributions to education and collegiality. This holistic recognition emphasizes the importance of fostering a vibrant academic community where cutting-edge research is seamlessly integrated with high-quality teaching and collaborative spirit, thereby nurturing an ecosystem where scientific excellence thrives.
David Engblom’s work continues to inspire the scientific and medical communities, illustrating how dedicated inquiry into the brain’s response to systemic inflammation can unravel fundamental mechanisms underlying human sickness behavior. His achievements underscore the critical need to view illness through both biological and psychological lenses, ultimately paving the way for therapies that address the totality of the patient’s experience.
Subject of Research: Neurobiology of brain-immune interactions affecting sickness behavior and neuropsychological symptoms in inflammatory and infectious diseases.
Article Title: Professor David Engblom Awarded 2026 Onkel Adam Prize for Neuroimmune Research on Sickness Behavior
News Publication Date: Not specified in the original content
Web References: https://mediasvc.eurekalert.org/Api/v1/Multimedia/535f9a0f-f0d9-4d45-b3c2-582bf6c99d70/Rendition/low-res/Content/Public
Image Credits: Anna Nilsen/Linköping University
Keywords: Neurobiology, Immune system, Inflammation, Sickness behavior, Cytokines, Neuroimmune communication, Rheumatoid arthritis, Inflammatory bowel disease, Neuropsychiatry, Medical education, Onkel Adam Prize, Linköping University
